期刊文献+

3种中药成分对CYP2C9酶的影响 被引量:3

Effects of Quercetin, Paeoniflorin and Oleanolic Acid on CYP2C9 Activities in Vitro
下载PDF
导出
摘要 目的评价槲皮素、芍药苷、齐墩果酸对CYP2C9酶活性的抑制作用,为临床合理用药提供参考。方法利用大鼠肝微粒体,以甲苯磺丁脲作为评价CYP2C9活性的体外探针,以高效液相色谱法测定代谢产物羟基甲苯磺丁脲生成量,评价槲皮素、芍药苷、齐墩果酸对CYP2C9酶的抑制作用。以磺胺苯吡唑为阳性对照,分别计算槲皮素、芍药苷、齐墩果酸的抑制率,绘制抑制曲线并计算半数抑制浓度(IC_(50)值)。结果 3种中药成分对CYP2C9均有一定的抑制作用,槲皮素、芍药苷、齐墩果酸IC_(50)分别为15.343,49.361,4.115μmol·L^(-1),其中齐墩果酸的抑制作用最强,而芍药苷作用效果不明显。结论齐墩果酸可中等强度抑制CYP2C9酶活性,而槲皮素和芍药苷的酶活性抑制作用较弱。 Objective To investigate the effects of quercetin, paeoniflorin and oleanolic acid on the activities of CYP2 C9 enzymes in vitro for clinical combination therapy. Methods Tolbutamide served as in vitro probes to evaluate CYP2 C9 activity in liver microsome. HPLC method was used to detect themetabolites,hydroxytoluene sulfobutamide production and to evaluate the effects of quercetin, paeoniflorin and oleanolic acid on the activities of CYP2 C9 enzymes. Inhibition rate and IC50 of quercetin, paeoniflorin and oleanolic acid were calculated with sulfaphenazole as positive control. Results Among the 3 active constituents tested, oleanolic acid was found to be a moderate inhibitor on CYP2 C9 with IC50 of 4.115 μmol·L-1. Quercetin and paeoniflorin was a poor inhibitor for CYP2 C9 with IC50 of 15.343 and 49.361 μmol·L-1, respectively. Conclusion Oleanolic acid is a moderate inhibitor of CYP2 C9, while quercetin, paeoniflorinweakly suppresses the activity of CYP2 C9.
作者 范宰文 马思琪 徐爱军 王亚蒂 FAN Zaiwen;MA Siqi;XU Aijun;WANG Yadi(School of Basic Medical Science,North China University of Science and Technology,Tangshan 063000,China)
出处 《医药导报》 CAS 北大核心 2019年第4期486-490,共5页 Herald of Medicine
基金 华北理工大学创新训练项目(X2016244) 河北省中医药管理局科研计划项目(2013161)
关键词 槲皮素 芍药苷 齐墩果酸 CYP2C9 抑制作用 肝微粒体 Quercetin Paeoniflorin Oleanolic acid CYP2C9 Inhibition Liver microsomes
  • 相关文献

参考文献4

二级参考文献54

  • 1陈洁,彭仁琇,杨静,吕靖峰.18α-甘草酸二铵与格列本脲联用对实验性糖尿病大鼠糖代谢的影响及其机制[J].中国药理学与毒理学杂志,2005,19(4):274-279. 被引量:8
  • 2程婕,杨凌.细胞色素P450氧化还原酶的研究进展[J].中国药理学通报,2006,22(2):129-133. 被引量:26
  • 3刘艳,黄丽军,王珍,张一飞,朱大岭.尼扎替丁对大鼠CYP1A2亚型的影响[J].中国药理学通报,2006,22(7):796-799. 被引量:5
  • 4Park JY, Kim KA, Kang MH, et al. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects[J]. Clin Pharmacol Ther, 2004,75 (3):157--162.
  • 5Rost KL, Brosicke H, Brockmoller J, et al. Increase of cytochrome P450IA2 activity by ome prazole: evidence by the 13C -[N 3-methyl]-caffeine breath test in poor and extensive metabolizers of mephenytoin[J]. Clin Pharmacol Ther, 1992, 52 (2) :170- 180.
  • 6Loboz KK, Gross AS, Williams KM, et al. Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity[J]. ClinPharmacolTher, 2006, 80(1):75 --84.
  • 7Jayasagar G, Krishna Kumar M, Chandrasekhar K, et al. Influence of rifampicin pretreatment on the pharmacokinetics of celecoxib in healthy male volunteers[J]. Drug Metabol Drug Interact, 2003, 19 (4):287 -295.
  • 8Girre C, LucasD, Hispard E, et al. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics [J ]. Biochem Pharmacol, 1994, 47(9) :1503--1508.
  • 9Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study[J]. J Acquir Immune Defic Syndr, 2005, 39(3) ..307--312.
  • 10Niemi M, Backman JT, Neuvonen M, et al. Rifampin decreases the plasma concentrations and effects of repaglinide[J]. Clin Pharmacol Ther, 2000, 68(5):495--500.

共引文献40

同被引文献18

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部